Latest filing published 23 Jul 2020 for Pandion Therapeutics, Inc., €156k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mitchell Mutz: trading record in brief
Mitchell Mutz appears in our data through filings on Pandion Therapeutics, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 21 July 2020, with 3 filings.
On the market, this insider has only ever bought: 2 purchases, €720k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The latest filing, published on 23 July 2020, reports an open-market purchase of €156k in Pandion Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mitchell Mutz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$18.0021.7% of flowCommon StockSEC:0000899243-20-020215:2Canonical exit: 19 Oct 2020 (T+90)
- 3,049,973 sharesCommon StockSEC:0000899243-20-020215:0
- 36,111 shares@ US$18.0078.3% of flowCommon StockSEC:0000899243-20-020215:1Canonical exit: 19 Oct 2020 (T+90)
3 of 2 declarations
